Sun Pharmaceutical Industries Limited Profit Margin

The latest profit margin for SUNPHARMA.BO is 20.19% as of June 2026. That compares with 19.29% in the prior-year period — up 4.7% year over year. That is above the sector sector average of 13.23%. Investors often review this figure alongside Sun Pharmaceutical Industries Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, SUNPHARMA.BO's profit margin moved from 19.29% to 20.19% — a 4.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sun Pharmaceutical Industries Limited's valuation or profitability profile.

Against its sector companies, SUNPHARMA.BO currently prints 20.19% for profit margin, while the sector average sits near 13.23%. That is roughly 52.6% above the sector mean. Large gaps often invite a closer look at Sun Pharmaceutical Industries Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Sun Pharmaceutical Industries Limited converts resources into returns. At 20.19%, SUNPHARMA.BO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 19.29% in the prior-year period — up 4.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SUNPHARMA.BO's profit margin (20.19%), review year-over-year change from 19.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.